Literature DB >> 10199874

Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X.

M Bøttcher1, H E Botker, H Sonne, T T Nielsen, J Czernin.   

Abstract

BACKGROUND: Impaired vasodilatation capacity in patients with angina pectoris and a normal coronary arteriogram (syndrome X [SX]) has been reported. Most studies report on the response in epicardial vessels. This does not necessarily reflect compromised myocardial microcirculation. Lack of the NO precursor L-arginine has been suggested as a possible cause. METHODS AND
RESULTS: Myocardial blood flow (MBF) was measured, using PET, at rest (MBF-rest) and during intravenous dipyridamole (MBF-DIP) in 25 women (mean age 53+/-7 years) with SX. Thirty healthy volunteers served as controls. One group (A) consisted of 15 age-matched female volunteers (54+/-10 years). The other control group consisted of 15 young healthy women (B; 24+/-5 years). In 12 SX patients, MBF-rest and MBF during cold pressor testing were also measured after infusion of L-arginine (6.7 g/min for 45 minutes). The increase in MBF after cold pressor testing was similar in the SX group compared with controls. L-arginine did not affect MBF-rest (0.83+/-0.14 versus 0.89+/-0.13 mL. g-1. min-1) or MBF after cold pressor test (0.95+/-0.10 versus 1. 03+/-0.17 mL. g-1min-1). In contrast, the hyperemic response to DIP was blunted compared with the group A controls (1.68+/-0.49 versus 2. 34+/-0.45 mL. g-1. min-1, P<0.05); this resulted in a significant reduction of the coronary flow reserve in SX patients relative to controls (2.03+/-0.53 versus 2.96+/-0.63 mL. g-1. min-1, P<0.01).
CONCLUSIONS: In patients with SX, the microcirculatory response to cold, reflecting the endothelium function, is normal and unaltered by intravenous L-arginine. This suggests preserved microcirculatory endothelial function. However, a markedly attenuated hyperemic flow and flow reserve after DIP suggest a dysfunction of the adenosine-mediated endothelium-independent vasodilatation at the microcirculatory level in these patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199874     DOI: 10.1161/01.cir.99.14.1795

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  31 in total

1.  Nuclear imaging and endothelial dysfunction.

Authors:  M Güthlin; F M Bengel; M Schwaiger
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

2.  Insulin resistance is a major determinant of myocardial blood flow impairment in anginal patients.

Authors:  Riccardo Liga; Daniele Rovai; Tiziana Sampietro; Cecilia Vecoli; Giancarlo Todiere; Chiara Caselli; Giuseppe Rossi; Antonio L'abbate; Danilo Neglia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-11       Impact factor: 9.236

Review 3.  Cardiac syndrome X: a critical overview and future perspectives.

Authors:  G A Lanza
Journal:  Heart       Date:  2006-01-06       Impact factor: 5.994

Review 4.  Assessment of coronary endothelial function using PET.

Authors:  Keiichiro Yoshinaga; Osamu Manabe; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

Review 5.  Coronary microvascular dysfunction, microvascular angina, and treatment strategies.

Authors:  Mark A Marinescu; Adrián I Löffler; Michelle Ouellette; Lavone Smith; Christopher M Kramer; Jamieson M Bourque
Journal:  JACC Cardiovasc Imaging       Date:  2015-02

Review 6.  Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management.

Authors:  Kamlesh Kothawade; C Noel Bairey Merz
Journal:  Curr Probl Cardiol       Date:  2011-08       Impact factor: 5.200

7.  Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

Authors:  Carl J Pepine; R David Anderson; Barry L Sharaf; Steven E Reis; Karen M Smith; Eileen M Handberg; B Delia Johnson; George Sopko; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

Review 8.  Cardiac Syndrome X: update 2014.

Authors:  Shilpa Agrawal; Puja K Mehta; C Noel Bairey Merz
Journal:  Cardiol Clin       Date:  2014-06-02       Impact factor: 2.213

Review 9.  Myocardial perfusion echocardiography and coronary microvascular dysfunction.

Authors:  Giuseppe Barletta; Maria Riccarda Del Bene
Journal:  World J Cardiol       Date:  2015-12-26

10.  Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome X.

Authors:  Maciej Haberka; Katarzyna Mizia-Stec; Zbigniew Gasior; Magdalena Mizia; Joanna Janowska; Michał Holecki; Barbara Zahorska-Markiewicz
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.